A Randomized, Double-blind, Placebo-Controlled, Crossover Study Assessing the Pharmacodynamic Effects of Dapoxetine Concomitantly Administered in Subjects Taking Terazosin.

Trial Profile

A Randomized, Double-blind, Placebo-Controlled, Crossover Study Assessing the Pharmacodynamic Effects of Dapoxetine Concomitantly Administered in Subjects Taking Terazosin.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Dapoxetine (Primary) ; Terazosin
  • Indications Benign prostatic hyperplasia; Depressive disorders; Hypertension; Premature ejaculation
  • Focus Pharmacodynamics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 18 Jun 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
    • 18 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jun 2012 Actual patient number is 23 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top